Kevin Yeaman Sells 6,751 Shares of Dolby Laboratories (NYSE:DLB) Stock

by · The Markets Daily

Dolby Laboratories (NYSE:DLB – Get Free Report) CEO Kevin Yeaman sold 6,751 shares of the company’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the sale, the chief executive officer owned 98,377 shares in the company, valued at approximately $6,614,869.48. This trade represents a 6.42% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Dolby Laboratories Stock Performance

DLB stock traded up $0.29 during mid-day trading on Wednesday, reaching $67.09. The company had a trading volume of 575,384 shares, compared to its average volume of 610,696. The firm has a fifty day simple moving average of $66.88 and a 200 day simple moving average of $71.25. The company has a market capitalization of $6.41 billion, a price-to-earnings ratio of 25.51 and a beta of 0.89. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66.

Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. The firm had revenue of $307.02 million for the quarter, compared to analyst estimates of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.61 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. As a group, analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Analyst Ratings Changes

DLB has been the subject of a number of recent research reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday. Barrington Research decreased their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research note on Wednesday, November 19th. Robert W. Baird started coverage on Dolby Laboratories in a report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Baird R W raised Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Finally, Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.

Check Out Our Latest Analysis on DLB

Institutional Trading of Dolby Laboratories

Several hedge funds have recently modified their holdings of DLB. Cetera Investment Advisers grew its position in Dolby Laboratories by 6.1% during the first quarter. Cetera Investment Advisers now owns 4,883 shares of the electronics maker’s stock worth $392,000 after buying an additional 282 shares during the period. Nuveen LLC purchased a new stake in shares of Dolby Laboratories during the 1st quarter worth approximately $16,890,000. Russell Investments Group Ltd. grew its holdings in shares of Dolby Laboratories by 53.7% in the 1st quarter. Russell Investments Group Ltd. now owns 62,918 shares of the electronics maker’s stock worth $5,051,000 after acquiring an additional 21,994 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories in the 1st quarter valued at approximately $29,000. Finally, Ethic Inc. acquired a new position in Dolby Laboratories during the first quarter worth $536,000. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

Featured Stories